New article published today by @ClaraMosq on new #MachineLearning#algorithm to automatically detect meals and estimate size of meal for use within fully automated insulin delivery for people with #T1D
https://t.co/NxVXpSCFHJ
I have a small request for my medical and paramedical colleagues - please can you take 20 seconds from your day and complete this brief survey. I’m hoping to bring something special to medical practitioners in the furniture….thanks much!
https://t.co/pkI0PAfTXY
2023 is our 25th year as a company, a momentous milestone that marks a quarter century of our devotion to science & to patients.
We'll be celebrating our 25th by sharing the moments & people that have made us into the company we are today. #Cyto25
https://t.co/FIyBA9tvih
#HappyThanksgiving from all of us at Cytokinetics!
We’re #thankful for a lot, but we’re especially thankful for our amazing team of employees who work hard every day toward our collective goal of improving the lives of patients with diseases of impaired muscle function.
So proud of our #HCM team and our patients. We just evaluated our 50th patient for aficamten, a cardiac myosin inhibitor. & we had a cake with asymmetrical septal hypertrophy, a myectomy and a sarcomere unit - made by the brilliant MLL ( https://t.co/O8eCYJmG1W )
#CardioTwitter
@MasriAhmadMD This is absolutely amazing. You and your team have contributed to so much in #hcm and #amyloid by helping (in the most significant manner) move the needle and bring new treatments for our patient. Thank you all for a magnifico job.
@Cytokinetics Keeping good things coming down the pipeline. So much to look forward to in the clinical research arena! Thanks for the stellar and impressive work!
A few weeks ago, we hosted our first annual Cytokinetics Research Day. It was a jam-packed day with excellent presentations from our colleagues in research showcasing their work. We loved taking a dive into the innovative research taking place that powers our continued progress.
Last week we hosted Jillian, a member of our #HCM Patient & Caregiver Advisory Council, at our SSF office. While onsite, Jillian saw firsthand how she & others like her inspire us to do the work that we do. Learn more about HCM and Jillian’s journey here: https://t.co/wEegIb5Anh
We are excited to announce that we have been recognized as one of @FortuneMagazine's Best Workplaces in BioPharma in 2022! #BestWorkplaces
We are honored to be a best workplace & are grateful to our wonderful Cytokinetics team. https://t.co/gIf956JkWi
Our paper on the first-in-human study of #aficamten is out with an editorial by Zoltan Papp - thanks to all those that contributed! We are now studying #aficamten in a Phase 3 clinical trial, #SEQUOIAHCM. Privileged to work with wonderful collaborators worldwide #teamwork.